Avet Pharmaceuticals Inc.
Mark Wojtko is an experienced finance professional currently serving as Manager of Revenue Reporting at Avet Pharmaceuticals since January 2020. Prior roles include Senior Accountant at Impax Laboratories, Associate Director of Revenue Reporting at Amneal Pharmaceuticals from July 2017 to January 2020, and Senior Accountant at Air Products Healthcare from January 2007 to September 2009. Mark Wojtko holds a Master of Science in Finance from Penn State University (1984-1989) and an MBA in Finance from Philadelphia University.
This person is not in any offices
Avet Pharmaceuticals Inc.
Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Avet Pharmaceuticals provides high quality generic medicines that help patients and practitioners achieve affordable healthcare solutions. Our global supply chain network is built around centers of manufacturing and scientific excellence to provide you with the highest level of quality, safety, value and service in generics. Our drug portfolio consists of numerous products across a wide range of therapeutic categories, including: cardiovascular, oncology, metabolic disease, anti-infective, infusion and pain management. We are focused on widely utilized, established products as well as niche, high barrier-to-entry products that have limited competition and long life cycles.